AEDV Registry of Primary Cutaneous Lymphoma
Spanish Academy of Dermatology and Venereology (AEDV) Registry of Primary Cutaneous Lymphoma
1 other identifier
observational
2,000
1 country
14
Brief Summary
Registry of patients with Primary Cutaneous Lymphoma seen at participating centers in Spain. The registry will identify patients with this disease and includes information about stage, diagnostic and therapeutic interventions and willingness to participate in further studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2016
Longer than P75 for all trials
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 18, 2018
CompletedFirst Posted
Study publicly available on registry
August 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedMarch 31, 2022
March 1, 2022
8.3 years
July 18, 2018
March 15, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Maximum TNM stage
Proportion
Through study completion, an average every 1 year
Therapeutic groups used
Including drugs, phototherapy, radiotherapy and procedures (blood marrow transplant)
Through study completion, an average every 1 year
Mortality
Rate
Through study completion, an average every 1 year
Interventions
Eligibility Criteria
Study population should be an accurate representation of patients with primary cutaneous lymphoma in Spain
You may qualify if:
- All consecutive patients with primary cutaneous lymphoma
You may not qualify if:
- Not willing to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (14)
Hospital Clinic
Barcelona, Spain
Hospital Universitario Basurto
Bilbao, Spain
Hospital General de Ciudad Real
Ciudad Real, Spain
hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Spain
C.H.U. Insular-Materno Infantil
Las Palmas de Gran Canaria, Spain
H.U. Fundación Jiménez Díaz
Madrid, Spain
Hospital 12 de Octubre
Madrid, Spain
Hospital Universitario Príncipe de Asturias
Madrid, Spain
Complejo Hospitalario de Navarra
Pamplona, Spain
CHOP-Hospital de Montecelo
Pontevedra, Spain
H.U. Nuestra Señora de la Candelaria
Santa Cruz de Tenerife, Spain
H.U. Virgen del Rocío
Seville, Spain
Hospital General Universitario de Valencia
Valencia, Spain
Hospital Valencia-Clínico Malva-Rosa
Valencia, Spain
Related Publications (1)
Penate Y, Servitje O, Machan S, Fernandez-de-Misa R, Estrach MT, Acebo E, Mitxelena J, Ramon MD, Florez A, Blanes M, Morillo M, Medina S, Bassas J, Zayas A, Espinosa P, Perez A, Gonzalez-Romero N, Dominguez JD, Muniesa C, Lopez Robles J, Combalia A, Yanguas I, Suh H, Polo-Rodriguez I, Bielsa I, Mateu A, Ferrer B, Descalzo MA, Garcia-Doval I, Ortiz-Romero PL. The First Year of the AEVD Primary Cutaneous Lymphoma Registry. Actas Dermosifiliogr (Engl Ed). 2018 Sep;109(7):610-616. doi: 10.1016/j.ad.2018.03.006. Epub 2018 Apr 19. English, Spanish.
PMID: 29680323BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pablo Ortiz, MD, PhD
Hospital 12 de Octubre
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2018
First Posted
August 24, 2018
Study Start
September 1, 2016
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
March 31, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share